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Summary
Recent advances in high-throughput sequencing
present a new opportunity to deeply probe an organ-
ism’s transcriptome. In this study, we used Illumina-
based massively parallel sequencing to gain new
insightintothetranscriptome(RNA-Seq)ofthehuman
malaria parasite, Plasmodium falciparum. Using data
collected at seven time points during the intraerythro-
cytic developmental cycle, we (i) detect novel gene
transcripts; (ii) correct hundreds of gene models; (iii)
propose alternative splicing events; and (iv) predict 5
and 3 untranslated regions.Approximately 70% of the
uniquesequencingreadsmaptopreviouslyannotated
protein-coding genes. The RNA-Seq results greatly
improve existing annotation of the P. falciparum
genome with over 10% of gene models modiﬁed. Our
data conﬁrm 75% of predicted splice sites and identify
202 new splice sites, including 84 previously unchar-
acterized alternative splicing events. We also discov-
ered 107 novel transcripts and expression of 38
pseudogenes, with many demonstrating differential
expression across the developmental time series. Our
RNA-Seq results correlate well with DNA microarray
analysis performed in parallel on the same samples,
and provide improved resolution over the microarray-
basedmethod.ThesedatarevealnewfeaturesoftheP.
falciparum transcriptional landscape and signiﬁcantly
advanceourunderstandingoftheparasite’sredblood
cell-stage transcriptome.
Introduction
Plasmodium falciparum malaria is responsible for more
than one million deaths annually, most of which occur in
young children (Breman, 2001). For several decades, the
development of new antimalarial compounds has been
slow, mostly due to a lack of well-deﬁned Plasmodium-
speciﬁc targets, adding to a growing concern as estab-
lished drugs become ineffective due to widespread
resistance in the ﬁeld (Arav-Boger and Shapiro, 2005). In
2002, the genome of the 3D7 clone of P. falciparum was
sequenced (Gardner et al., 2002), renewing hope that
progress towards reducing the burden of malaria would
be greatly accelerated. The P. falciparum genome
encodes roughly 5400 genes and has the lowest G+C
content (19%) of any genome sequenced to date.
Approximately half of the predicted coding sequences
(CDSs) are uncharacterized, with little sequence similarity
outside the Plasmodium genus, and a large number of
genes and gene families are unique to P. falciparum.
Furthermore, the proteome contains a high proportion of
low complexity sequence where poly-asparagine regions
are highly prevalent (Aravind et al., 2003).
Making use of these sequence data, two groups in 2003
used different DNA microarray platforms (70-mer oligo-
nucleotide based, and Affymetrix) to measure transcript
levels during the intraerythrocytic developmental cycle
(IDC) of the P. falciparum parasite. These studies
revealed a highly ordered cascade of gene expression
(Bozdech et al., 2003; Le Roch et al., 2003). A later study
demonstrated that gene expression levels were similar
between different strains of disparate geographical origin,
suggesting highly conserved modes of transcriptional
regulation during development (Llinas et al., 2006). More
recently gene expression studies in a variety of other life
cycle stages have been performed (Young et al., 2005;
Siau et al., 2008; Tarun et al., 2008). Previous efforts to
sequence RNA transcripts from P. falciparum have
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have analysed a small fraction of the full-length cDNA
sequences from the Plasmodium spp. (Wakaguri et al.,
2009a,b). These low-resolution studies already demon-
strated inaccuracies in P. falciparum gene model predic-
tions and suggested that both variable length untranslated
regions (UTRs) and diversity in splicing were prevalent in
the transcriptome.
The depth of sequence obtainable with highly
parallel sequencing technologies such as Illumina’s
GenomeAnalyzer (Bentley et al., 2008), 454 (Droege and
Hill, 2008), SOLiD (Ondov et al., 2008) (http://solid.
appliedbiosystems.com) platforms make it possible to
sequence cDNA and obtain high coverage of all tran-
scribed genes. In 2008, the ﬁrst applications of high-
throughput sequencing technologies to the direct
sequencing of expressed RNA transcripts (RNA-Seq)
from human tissue (Pan et al., 2008; Sultan et al., 2008),
yeast (Nagalakshmi et al., 2008; Wilhelm et al., 2008) and
mouse (Mortazavi et al., 2008) were reported. RNA-Seq
can reliably be used to correct gene annotations, conﬁrm
new and existing splice forms, analyse UTR regions,
deﬁne non-coding RNAs or ﬁnd new transcripts (Wang
et al., 2009). In general, samples for RNA-Seq are pro-
duced by reverse transcription of puriﬁed mRNA using
oligo(dT) and random priming. The sequencing results,
typically short reads between 25 and 75 bp, as either
singletons or as paired-end reads can then be mapped
onto a reference genome with computational tools such
as SSAHA2 (Ning et al., 2001), MAQ (Li et al., 2008),
BWA (Li and Durbin, 2009) and ELAND (http://www.
illumina.com/). From the mapping position of each read,
the cumulative occurrence per base pair can be calcu-
lated to generate genome coverage plots.
In this study, we applied RNA-Seq to seven time points
from the asexual IDC of P. falciparum with the aim of
capturing features associated with all expressed RNA
transcripts and measuring splicing dynamics that occur
duringparasitedevelopment.DespitethehighA+Tcontent
of the genome, which presents challenges for mapping
transcripts, we were able to detect transcription of 4871
genes during the 48 h IDC. While a previous report had
demonstrated the feasibility of the short read sequencing
approach for P. falciparum, these results were based on
sequencing a biased mRNA sample prepared using an
oligo(dT) affinity strategy (Sorber et al., 2008). Our meth-
odology provides an improvement in genome-wide
sequence coverage due to an enhanced enrichment strat-
egy for mRNAs. Overall, our results indicate a higher level
oftranscriptionthanpreviouslyrealizedbyDNAmicroarray
studies due to our ability to detect far more low abundance
species.Wehaveidentiﬁedover100newtranscriptsinthe
genome and reannotated more than 10% of the existing
gene models. Finally, we were able to identify numerous
alternativesplicingeventsandfurtherourunderstandingof
5′ and 3′ UTRs, which may lend further insight into gene
regulation in this important human pathogen.
Results
Comparison of depletion methods
Due to the high abundance of ribosomes in all cells,
ribosomal RNAs (rRNAs) account for over 90% of all
cellular RNAs. Therefore, the most standard method for
rRNA depletion is to affinity purify polyadenylated mRNA
species using an oligo(dT) sepharose. For P. falciparum,
this methodology does not work effectively because of the
high A+T content of the genome (80% in coding and 90%
in non-coding regions). In previous DNA microarray-
based genome-wide transcriptome analyses, this effect
has largely been ignored with cDNA being synthesized
directly from total RNA using oligo(dT) followed by in vitro
reverse transcription (Chen et al., 2003) or a combination
of oligo(dT) and random priming (Bozdech et al., 2003).
Either of these methods results in an over-representation
of parasite rRNAs in the material assayed on the microar-
ray but, in general, does not compromise the performance
of the microarray. However, for a sequence-based
approach, removal of abundant rRNA is essential in order
to maximize coverage of other low expressed transcripts,
because the total number of possible reads per machine
run is ﬁnite.
In an attempt to remove a signiﬁcant fraction of plas-
modial rRNAs, we tested two possible mRNA enrichment
strategies. The ﬁrst method is affinity-based and targets
26 high abundance rRNA species as well as the 32 most
abundant mRNA species in P. falciparum such as the
histones, merozoite surface protein 1 and several heat
shock proteins (based on previous microarray data sets)
(Bozdech et al., 2003; Chen et al., 2003) (see Table S1).
To accomplish this, we ﬁrst bound 58 biotin-tagged DNA
oligonucleotides to magnetic streptavidin beads and then
incubated isolated total RNA in the presence of the immo-
bilized (complementary) DNA sequences. Subsequently,
the unbound RNAs were isolated and subjected to
reverse transcription for Illumina sequencing (see Experi-
mental procedures). Our second method was to treat with
Terminator™ 5′-Phosphate-Dependent Exonuclease
(Epicentre) (a processive 5′-3′ exonuclease that digests
RNA containing a free 5′-monophosphate end, thereby
removing rRNAs, transfer RNAs, and apicoplast-derived
RNAs) and then to affinity deplete with our 58 biotin-
tagged DNA oligonucleotides. Independent sequencing
runs were performed to compare the effectiveness of
these approaches (Table 1, Table S1). Although compa-
rable numbers of reads (> 4.5 million) were attained for all
three samples, 60% of the reads from the undepleted
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tion strategies and covered only 1% of the genome more
than 10 times. However, using the affinity oligonucleotide
depletion or combined oligonucleotide and Terminator™
depletion strategies, 58% and 21%, respectively, mapped
to the depleted regions. Furthermore, the percentage of
the genome with more than 10¥ coverage increased to
2% and 7% respectively, and overall genome coverage
increased more than ﬁve times over the undepleted
sample. Finally, the genome coverage is overall much
greater in the depleted samples and is maximal (51%) in
the combined Terminator™ and oligonucleotide-depleted
sample. Based on these results, we conclude that for
enrichment of P. falciparum mRNAs for high-throughput
sequencing, the combined oligonucleotide and Termina-
tor™ exonuclease depletion strategy was the best. We
therefore used a combined method of Terminator™ exo-
nuclease depletion in conjunction with the biotin-
oligonucleotide depletion strategy for all subsequent
experiments.
Sequencing and data processing
Using highly synchronized 3D7 parasites, we collected
RNA samples at seven different time points every 8 h for
48 h, thus capturing the entire IDC of P. falciparum from
the ring stage to mature schizonts. Total RNA samples
were processed as described above and cDNAgenerated
by reverse transcription using a 1:1 combination of
oligo(dT) and random nonamer primers (see Experimen-
tal procedures). Illumina sequencing reads were mapped
and processed using standard methods developed at the
Sanger Institute (see Fig. 1, Experimental procedures).
Complete mapping statistics are presented in Table S2. In
summary, between 51% (early rings) and 20% (late sch-
izonts) of the reads mapped uniquely against the genome.
Of these, around 50–60% of the reads mapped to pre-
dicted protein-coding genes and 20% mapped within
Table 1. RNA-Seq mapping statistics against P. falciparum genome.
Sequencing run
Undepleted
Depleted by
speciﬁc oligos
Depleted by exonuclease
and speciﬁc oligos
Total reads 5 161 203 5 657 762 4 847 379
% Mapped
a 94 92 86
% Mapped to unique locations
a 15 24 52
Reads mapped to rRNA 3 120 248 3 269 563 1 034 004
% Reads mapped to rRNA 60% 58% 21%
Fold coverage 1.14 2.05 3.75
% Genome not covered 72 65 49
% Genome covered, < 5-fold 96 93 84
% Genome covered, > 10-fold 1 2 7
Max. coverage across in coding sequences
b 11 008 4 697 7 061
Max. coverage, genome-wide
b 73 864 95 351 64 552
Max. average coverage in coding sequences
b 2 774 1 296 1 598
Genes with gmean coverage > 5
b 749 1 205 2 438
Genes with gmean coverage > 10
b 93 191 499
Summary statistics of mapping of Illumina sequencing reads on to P. falciparum 3D7 genome from RNA-Seq runs after depletion by speciﬁc
oligonucleotides and by exonuclease digestion. Oligonucleotides used for speciﬁc depletion have been described in Table S1.
a. Reads mapped using SSAHA2.
b. Coverage determined using MAQ; non-unique reads randomly partitioned over repeats.
Fig. 1. Workﬂow of short read processing for gene expression
analysis by RNA-Seq. The Illumina sequencing reads are mapped
with SSAHA2 (Ning et al., 2001) against the Plasmodium
falciparum 3D7 genome. After mapping, splice reads and coverage
plots are obtained. The splice reads are used to conﬁrm or ﬁnd
new splice sites as well as alternative splice sites. The coverage
plots show the RNA expression levels over each base pair of the
genome. To calculate the expression per CDS per time point, the
coverage plots and the uniqueness plots are used. Uniqueness
plots indicate the uniqueness of a particular region of the genome.
Using the coverage, it is possible to identify incorrect annotation,
novel transcripts and potential untranslated regions (UTRs) of
protein coding transcripts (as described in the text).
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UTRs. For each individual time point, we calculated a
transcript abundance value based on the geometric mean
depth of coverage (see below) of all sequencing reads
corresponding to a given genomic region (see Experimen-
tal procedures). These mapped regions include previously
annotated genes (Table S3), annotated pseudo genes
(Table S4) and novel genes predicted by our results
(Table S5). The temporal data capture the dynamic varia-
tion of mRNA abundance values during the IDC and cor-
relate well with previous microarray studies (see below).
The total range of transcriptional activity captured by
these data varied by ﬁve orders of magnitude. Using data
from CDS only, variation in gene expression by a factor of
up to 8200 was observed.
Correlations to DNA microarray data
As these are the ﬁrst temporal, sequencing-based tran-
scriptome data generated from P. falciparum mRNAs
during the IDC, we wanted to directly compare and vali-
date our sequencing results with microarray data gener-
ated in parallel using the same RNA samples. Previous
studies have found variable correlations when measuring
gene expression with different technologies (Bloom et al.,
2009), suggesting that both methods have their biases
when compared with quantitative PCR. When plotted
according to the phase of gene expression, as previously
determined by Llinas et al. (2006), the well-established
cascade of gene expression is faithfully reproduced by
both data sets (Fig. 2A and B). The RNA-Seq and DNA
microarray data are in good agreement, with Pearson
correlations between these data sets ranging from 0.7 to
0.85 at various time points (Fig. 2C, Table S2).
In addition to the high correlation with microarray data,
we estimated the hours post invasion (hpi) for each time
point of the RNA-Seq in the IDC using a statistical
likelihood-based estimator that calculates the relative
temporal sequence and a generalized overview expres-
sion curve for each time point (Fig. S1) (Lemieux et al.,
2009). These data recapitulate the systematic temporal
progression of parasite development during this experi-
ment and demonstrate that the cultures are well
synchronized.
Transcriptome analysis
Our RNA-Seq data capture approximately 90% of the
predicted CDS in the P. falciparum genome. As the data
are highly variable across the length of a transcript, for
each predicted CDS locus in GeneDB (http://
www.genedb.org/), we have calculated an mRNA abun-
dance value based on the geometric mean of the
sequencing reads (Table S3). Many P. falciparum genes
Fig. 2. Expression proﬁles of 3975
annotated genes at seven time points in the
intra-erythrocytic developmental cycle (IDC) of
P. falciparum 3D7 and comparison of
RNA-Seq data with microarray data.
A. Heat map of genes expressed in the IDC
cycle (Bozdech et al., 2003) with the
RNA-Seq data.
B. Heat map of genes expressed in the IDC
cycle, derived from microarray experiments
using the identical biological samples.
C. Pearson correlation between the RNA-Seq
and the microarray data sets.
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reads cannot always be unambiguously aligned to these
regions. In order to correct for this mapping error we
have adjusted the geometric mean, using as a denomi-
nator the region of each gene that we calculate to be
mappable (see Experimental procedures). It is notable
that the percentage of uniquely mapping reads is lower
at the schizont stage than at other time points. This may
be explained both by the fact that this set of reads were
37 bp rather than 54 bp (and so were less likely to map
uniquely) and to the observation that the proportion of
proteins containing low complexity sequence appears
higher towards the end of the IDC (data not shown). The
data can easily be used to discriminate exons within a
given gene and to identify novel transcripts (Fig. 3).
Even for highly complex intron/exon structures such as
that seen for the GTPase activator (PF11_0152), a
coding gene that is comprised of 11 exons, we can
easily conﬁrm the predicted splice sites (Fig. 3). More-
over, adjacent genes with opposite temporal expression
proﬁles can be observed using the RNA-Seq data. For
example, PFI0180w (alpha tubulin) is maximally
expressed during the trophozoite stage, while the next
gene PFI0185w is not expressed, while the following
downstream gene, PFI0190w is a ring stage RNA
(Fig. 3).
For some sequenced transcripts, putative UTRs can be
discerned (Figs 3 and 4). However, in general the depth of
sequencing coverage of the UTRs is lower compared with
the exonic regions and is mostly attributable to the poor
mapping of the relatively short Illumina reads onto the
extremely high A+T-rich (> 90%) UTR regions. Unfortu-
nately, this RNA-Seq data set does not serve to capture
short non-protein coding transcripts previously predicted
by several groups (Chakrabarti et al., 2007; Mourier et al.,
2008; Mishra et al., 2009) because we used a fragment
sizecut-offaround200 bp,excludingpossibleshortRNAs.
Correction of gene models
The RNA-Seq data are highly informative for correcting
structural boundaries of predicted genes (Table 2). The
most common correction was elongation or shortening of
predicted intron/exon boundaries, in which case, the cov-
erage plots of all expressed time points unambiguously
drop towards zero before the splice site. For example, we
predicted a shortened ﬁrst exon for PF10_0022, a
member of the PHISTc exported protein family (Sargeant
et al., 2006) (Fig. 4) and conﬁrmed this experimentally by
RT-PCR and directed sequencing of the PCR product
across the splice junction (Fig. S2). Using the RNA-Seq
data, we performed a genome-wide update of all P. falci-
parum splice sites, incorporating mostly data from this
study but also changes due to homology to other recently
sequenced species (Carlton et al., 2008; Pain et al.,
2008) or expressed sequence tag evidence (Haas et al.,
Fig. 3. RNA-Seq coverage plots for selected genes and their corresponding expression proﬁles (expressed as gmean) at seven time points
in the intra-erythrocytic developmental cycle (IDC) of P. falciparum 3D7.
A. Expression proﬁle of a multi-exon gene PF11_0152 (GTPase activator) [maximal expression 423 (gmean)].
B. Expression proﬁles of three adjacent genes: PFI0180w (max expression 2000), PFI0185w (no expression) and PFI0190w (max expression
780) on chromosome 9, showing opposite temporal regulation of expression for PFI0180w (alpha tubulin – black proﬁle plot), PFI0190w (60S
ribosomal protein L32 – red proﬁle plot) and lack of expression for PFI0185w.
C. Expression proﬁle of a novel mlncRNA transcript (PF10TR002, see in Table S5) identiﬁed on Chr10 (max expression 580).
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predicted genes) 202 splice sites for new exons added,
with the majority being conﬁrmed by two or more RNA-
Seq read pairs. Despite low coverage of UTRs, we were
able to identify several gene models with strong UTR
signals, and report 192 spliced UTR events (with at least
two conﬁrming reads).
Splicing is highly prevalent throughout the P. falciparum
transcriptome. We used our RNA-Seq data to perform a
genome-wide analysis of splicing and splice-site variants
to identify a total of 8496 splice sites in 3D7. As expected,
our data conﬁrmed that the majority of splice sites in the
genome were previously properly predicted. However, our
data also serve to correct mispredicted splice sites and
identify new and alternative splice sites. For splice site
analysis, we used partially mapping reads (bridging
reads), where two segments of the sequencing read map
to different positions along the same chromosome but are
anchored in the genome by the other end of the read pair.
For new splice site reads, only a portion of the sequence
maps to the CDS sequence, calling for re-analysis of the
non-mapping segments (see Experimental procedures).
In total, 294 possible new splice sites containing canoni-
cal splice donors and acceptors were conﬁrmed by at
least two RNA-Seq reads (Table 2). All new gene model
predictions are available through GeneDB and have been
deposited at PlasmoDB.org version 6.0 (Bahl et al.,
2003).
Alternative splice sites
Using reads spanning existing and new splice sites, we
built an algorithm to identify alternative splicing (see
Experimental procedures). We identiﬁed four types of
alternative splice events: exon-skipping; intron retention/
creation; 3′ and 5′ alternative splicing (coordinate
changes to external exons) and 3′ and 5′ splicing that
results in an alternative start or stop codon (Table 3). Out
of a total of 84 alternative splice events, the most common
is the 3′ and 5′ alternative splicing (56 events), followed by
exon skipping (16 events). We required at least two con-
ﬁrming reads for a new splice site to be automatically
Fig. 4. Use of RNA-Seq data in correction of gene models in P. falciparum 3D7. An example is shown where a previously incorrect predicted
gene model was corrected using RNA-Seq evidence for the gene PF10_0022 [Plasmodium exported protein (PHISTc)]. The coverage plots
indicate that the ﬁrst exon is shorter by 27 bp at the 3′ end. The arrow and black boxed areas highlight the location of structural changes
incorporated in the gene PF10_0022. The correctly spliced form is conﬁrmed by 36 known bridging reads (green features). This new splice
site was conﬁrmed by RT-PCR (orange features). Coverage plots also identiﬁed the 5′ UTR in PF10_0022 (shown by grey striped feature).
The incorrect gene model was taken from the published version of the P. falciparum 3D7 genome (Gardner et al., 2002).
Table 2. Overview of changes to annotation of the P. falciparum 3D7 genome.
Previous
annotation
a
Modiﬁed
annotation
b Difference
Predicted protein coding genes 5 317 5 438 121
Changes to gene structures based on RNA-Seq evidence 423
Predicted spliced transcripts 2 870 2 952 82
Predicted splice sites 8 315 8 517 202
Conﬁrmed splice sites (by  1 Illumina read pair) 6 590 6 891 301
Conﬁrmed splice sites (by  2 Illumina read pairs) 6 095 6 389 294
% conﬁrmed splice sites (by  2 Illumina reads pairs) 73 75 2
Reads conﬁrming predicted splice sites 453 881 479 011 25 130
Overview of annotation changes in the P. falciparum 3D7 genome with the aid of the RNA-Seq data during the period between March, 2008 and
May, 2009.
a. Annotation from May 2008, produced without using RNA-Seq data.
b. Annotation from March 2009, edited using RNA-Seq data.
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Chr. New splice site
Number of
conﬁrming
reads
Alternative splicing
events Gene identiﬁer Product
1 294554.. 294928 3 Exon skipping PFA0345w Centrin-1
1 388453.. 388750 4 Exon skipping PFA0485w Phosphatidate cytidylyltransferase, putative
2 140595.. 140820 2 3′ and 5′ alternative PFB0140w Zinc ﬁnger protein, putative
2 231909.. 232099 10 3′ and 5′ alternative PFB0255w Conserved Plasmodium protein, unknown function
2 382875.. 383071 2 3′ and 5′ alternative PFB0410c Phospholipase A2, putative
2 412537.. 412701 3 3′ and 5′ alternative PFB0455w 60S ribosomal protein L37ae, putative
2 276441.. 276558 5 Alternative stop PFB0305c Merozoite surface protein 5
3 214831.. 215062 3 3′ and 5′ alternative PFC0200w 60S Ribosomal protein L44, putative
3 458474.. 458623 3 3′ and 5′ alternative PFC0441c SAC3/GNAP family-related protein, putative
3 553204.. 553287 13 3′ and 5′ alternative PFC0571c Conserved Plasmodium protein, unknown function
3 566965.. 567142 6 3′ and 5′ alternative PFC0582c Vesicle transport v-SNARE protein, putative
4 99991.. 100185 33 3′ and 5′ alternative PFD0070c riﬁn
4 673403.. 673580 2 3′ and 5′ alternative PFD0720w Conserved ARM repeats protein, unknown function
4 785847.. 785932 3 3′ and 5′ alternative PFD0850c Memo-like protein
5 1082779.. 1082882 2 3′ and 5′ alternative PFE1305c ADP-ribosylation factor GTPase-activating protein, putative
5 1147532.. 1147829 4 Exon skipping PFE1375c Conserved Plasmodium protein, unknown function
5 1202254.. 1202495 5 Intron creation PFE1465w Conserved Plasmodium protein, unknown function
6 1171453.. 1171616 2 3′ and 5′ alternative PFF1375c Ethanolaminephosphotrans ferase, putative
6 258869.. 258956 24 Intron creation PFF0300w RNA binding protein, putative
6 533969.. 534599 18 3′ and 5′ alternative PFF0630c Conserved Plasmodium protein, unknown function
6 533969.. 534618 42 Exon Skipping PFF0630c Conserved Plasmodium protein, unknown function
6 534448.. 534599 2 3′ and 5′ alternative PFF0630c Conserved Plasmodium protein, unknown function
6 534448.. 534618 6 3′ and 5′ alternative PFF0630c Conserved Plasmodium protein, unknown function
6 794834.. 794959 38 3′ and 5′ alternative PFF0920c Conserved Plasmodium protein, unknown function
7 80499.. 80835 3 Alternative stop MAL7P1.2 25 Plasmodium exported protein (PHISTa-like), unknown function
7 112961.. 113197 2 3′ and 5′ alternative MAL7P1.2 29 Cytoadherence linked asexual protein
7 137990.. 138206 2 3′ and 5′ alternative PF07_0004 Plasmodium exported protein, unknown function
7 1314328.. 1314516 21 3′ and 5′ alternative MAL7P1.1 60 Conserved Plasmodium protein, unknown function
8 553020.. 553217 11 3′ and 5′ alternative MAL8P1.1 06 Conserved Plasmodium protein, unknown function
8 227245.. 227377 19 3′ and 5′ alternative MAL8P1.1 43 Conserved Plasmodium protein, unknown function
8 284523.. 284611 2 3′ and 5′ alternative MAL8P1.1 38 Alpha/beta hydrolase, putative
9 115387.. 115522 18 3′ and 5′ alternative PFI0125c Serine/Threonine protein kinase, FIKK family
9 285483.. 285587 59 3′ and 5′ alternative PFI0280c Autophagocytosis-associated protein, putative
9 285483.. 285808 3 Exon skipping PFI0280c Autophagocytosis-associated protein, putative
9 169401.. 169747 3 Alternative stop PFI0175w Conserved Plasmodium protein, unknown function
9 527195.. 527472 2 Exon skipping PFI0560c Conserved Plasmodium protein, unknown function
9 749906.. 750048 2 3′ and 5′ alternative PFI0890c Organelle ribosomal protein L3 precursor, putative
9 857945.. 858202 18 Exon skipping PFI1030c Ubiquitin conjugating enzyme, putative
9 1135552.. 1135898 8 3′ and 5′ alternative PFI1375w Cytochrome C oxidase, putative
9 1219040.. 1219282 2 3′ and 5′ alternative PFI1490c Ran-binding protein, putative
9 1427723.. 1427820 7 Alternative start PFI1740c Ring-exported protein 2
10 122332.. 122507 7 3′ and 5′ alternative PF10_0028 RNA binding protein, putative
10 616830.. 617522 2 3′ and 5′ alternative PF10_0149 Cysteinyl-tRNA synthetase, putative
10 617363.. 617522 5 3′ and 5′ alternative PF10_0149 Cysteinyl-tRNA synthetase, putative
10 630332.. 630635 3 Exon skipping PF10_0153a Conserved Plasmodium protein, unknown function
10 1506427.. 1506546 1194 3′ and 5′ alternative PF10_0372 Antigen UB05
11 204951.. 205102 9 3′ and 5′ alternative PF11_0058 RNA polymerase subunit, putative
11 539968.. 540166 218 3′ and 5′ alternative PF11_0149 Rhomboid protease ROM1, putative
11 616746.. 616900 4 3′ and 5′ alternative PF11_0169 SNO glutamine amidotransferase, putative
11 736961.. 737116 3 3′ and 5′ alternative PF11_0202 Clathrin coat assembly protein, putative
11 1029280.. 1029486 14 3′ and 5′ alternative PF11_0273 DNAJ protein, putative
11 1431895.. 1433153 3 Alternative stop PF11_0377 Casein kinase 1, PfCK1
12 194966.. 195139 2 3′ and 5′ alternative PFL0190w Ubiquitin conjugating enzyme E2, putative
12 545253.. 545453 2 3′ and 5′ alternative PFL0610w Conserved Plasmodium protein, unknown function
12 556129.. 556311 9 3′ and 5′ alternative PFL0623c conserved Plasmodium membrane protein, unknown function
12 675551.. 675934 15 Exon skipping PFL0825c Conserved Plasmodium protein, unknown function
12 848566.. 848672 4 3′ and 5′ alternative PFL1015w Conserved Plasmodium protein, unknown function
12 1429555.. 1429746 5 Intron creation PFL1650w Conserved Plasmodium protein, unknown function
13 598721.. 598890 3 3′ and 5′ alternative MAL13P1. 70 Conserved Plasmodium membrane protein, unknown function
13 656337.. 656495 2 3′ and 5′ alternative MAL13P1. 82 Phosphatidylinositol synthase
13 656725.. 657067 3 Exon skipping MAL13P1. 82 Phosphatidylinositol synthase
13 670259.. 670473 22 3′ and 5′ alternative MAL13P1. 84 Protein kinase, putative
13 892554.. 892819 3 3′ and 5′ alternative MAL13P1. 118 3′,5′-cyclic nucleotide phosphodiesterase
13 1097484.. 1097716 2 Intron creation MAL13P1. 144 Translation initiation factor EIF-2B gamma subunit, putative
13 1097497.. 1097716 2 Intron creation MAL13P1. 144 Translation initiation factor EIF-2B gamma subunit, putative
13 1280278.. 1280427 5 3′ and 5′ alternative MAL13P1. 163 ER lumen protein retaining receptor 1, putative
13 2037484.. 2037617 5 3′ and 5′ alternative MAL13P1. 257 Conserved Plasmodium protein, unknown function
13 2093143.. 2093239 2 Intron creation MAL13P1. 267 conserved Plasmodium protein, unknown function
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included in the GeneDB database. In six instances
(PFF0630c, PFI0280c, PF10_0149, MAL13P1.144,
MAL13P1.267, MAL13P1.277) we found more than one
alternative splicing event in a single gene. Figure 5A
shows an example of two 5′ alternative splicing events for
PF14_0581 (putative apicoplast ribosomal component).
The new splice site occurs mostly in the 16 and 24 hpi
Table 3. cont.
Chr. New splice site
Number of
conﬁrming
reads
Alternative splicing
events Gene identiﬁer Product
13 2094689.. 2094839 5 Intron creation MAL13P1. 267 Conserved Plasmodium protein, unknown function
13 2242140.. 2242247 3 Exon skipping MAL13P1. 277 DNAJ-like protein, putative
13 2242140.. 2242464 4 Exon skipping MAL13P1. 277 DNAJ-like protein, putative
13 2438774.. 2438947 88 3′ and 5′ alternative MAL13P1. 303 Polyadenylate-binding protein, putative
13 2463514.. 2463766 10 Exon skipping MAL13P1. 306 Conserved Plasmodium protein, unknown function
14 361362.. 361530 3 3′ and 5′ alternative PF14_0089 Conserved Plasmodium protein, unknown function
14 446307.. 446640 12 Exon skipping PF14_0108 conserved Plasmodium protein, unknown function
14 448014.. 448158 4 3′ and 5′ alternative PF14_0778 Conserved Plasmodium membrane protein, unknown function
14 521860.. 522189 5 Exon skipping PF14_0128 Ubiquitin conjugating enzyme, putative
14 1079304.. 1079501 36 3′ and 5′ alternative PF14_0253 Conserved Plasmodium membrane protein, unknown function
14 1446211.. 1446527 24 Exon skipping PF14_0338 Conserved Plasmodium protein, unknown function
14 2016906.. 2017099 36 3′ and 5′ alternative PF14_0469 Transcription factor IIIb subunit, putative
14 2255846.. 2256076 9 3′ and 5′ alternative PF14_0526 Conserved Plasmodium protein, unknown function
14 2481102.. 2481202 41 3′ and 5′ alternative PF14_0581 Apicoplast ribosomal protein S10 precursor, putative
14 2587073.. 2587215 48 3′ and 5′ alternative PF14_0607 Conserved Plasmodium membrane protein, unknown function
14 2812903.. 2813007 2 3′ and 5′ alternative PF14_0653 Derlin-2, putative
Overview of alternative splicing events conﬁrmed by RNA-Seq Solexa reads over seven time points used in the study.
Fig. 5. Use of RNA-Seq data to detect
alternative splicing and exon skipping events
in the IDC transcriptome of P. falciparum 3D7.
A. Alternative splice sites for exon 4 of
PF14_0581 (putative apicoplast ribosomal
protein isoforms) highlighted by aligned
bridging reads (red) from early ring time
points. The boxed area highlights the location
of alternative splicing in the gene PF14_0581.
The dotted red line links read pairs from the
same template DNA. The blue bars show
reads that map to the borders of exons,
across an intron. Perfectly mapping reads are
not shown.
B. Example of exon skipping in PF14_0108 (a
predicted protein of unknown function). A new
splice form was indicated by a read mapping
across two introns and exon, and its read pair
(red). Both splice-forms were conﬁrmed by
RT-PCR (orange boxes). The boxed area
highlights the location of exon skipping in the
gene PF14_0108. Only the last eight exons of
PF14_0108 are shown in the ﬁgure.
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in the later time points. This observation brings up the
tantalizing possibility that alternative splicing is temporally
regulated during the P. falciparum lifecycle. Overall, we
did not detect a temporal bias for alternative splicing at
any speciﬁc time point. In another case of alternative
splicing in the PF14_0108 gene (unknown function), exon
skipping was detected. Both transcripts were validated by
RT-PCR and sequencing (Fig. S2).
Identiﬁcation of novel transcripts and expression
of pseudogenes
We carefully analysed the expression signals that mapped
neither to regions on the genome that correspond to anno-
tated genes nor to their likely UTRs. A region was called
positive (i.e. transcriptionally active) if a window of 60 bp
was fully covered and had a geometric mean score of 5 or
greater. All regions were veriﬁed by manual inspection.
Using these criteria, we identiﬁed 107 novel blood-stage
transcripts that were previously unknown (Table S5).
These appear to be non-protein coding as no bona ﬁde
protein-encoding gene prediction is possible for these
novel transcripts. With the methods used here we are
unable to determine from which strand these transcripts
arise. Such non-protein coding transcripts have been
described before as mRNA-like non-coding RNAs (mlnc
RNA) (Rodriguez et al., 2004; Griffiths-Jones, 2007).
Thereisgrowingevidenceforalargenumber(> 34 000)of
these mlncRNAs in the human genome (Carninci et al.,
2005). They are likely to be transcribed by RNA poly-
merase II but their function in most cases is unknown. One
exceptionisthemammalianXistmlncRNAtranscriptthatis
derived from a pseudogene and plays a vital role in
X-dosage compensation (Duret et al., 2006).The length of
these transcripts in P. falciparum varies from 57 to 8931 bp
(median is 918 bp) and the majority appear to be shared
with other Plasmodium parasites sequenced to date
(Table S5). We do not, however, have any experimental
evidence to suggest that these orthologous genomic
regionsaretranscribedduringthebloodstagesofinfection
in other Plasmodium parasites. We show the expression
proﬁle of one of these novel transcripts in Fig. 3.
There are 81 annotated pseudogenes in the P. falci-
parum 3D7 genome (Tables S4 and S5), of which we
detect transcription from 38 in our sequencing data. Of
these, 17 were previously found to be expressed in a
periodic manner during the IDC (Bozdech et al., 2003)
suggesting their recent evolutionary conversion to
pseudogenes.
Discussion
Using high-throughput sequencing (RNA-Seq), this study
provides the ﬁrst in-depth sequencing-based analysis of
the P. falciparum transcriptome, derived from seven time
points from the red blood cell stage of development.
Despite the high A+T content of this genome, our data
provide near-complete genome coverage of RNA tran-
scripts at single base pair resolution and provide signiﬁ-
cant improvement to our understanding of the global
transcriptome. We identify rare stage-speciﬁc alternative
splicing events, novel transcripts and low abundance tran-
scripts, and correct existing gene models using the deep
read coverage provided by Illumina sequencing. Our high-
coverage RNA-Seq data were made possible by the use
of a new strategy for depleting high-abundance tran-
scripts (predominantly rRNAs) that would otherwise domi-
nate the sequencing library. This consisted of a
combination of an exonuclease digestion, speciﬁc for
uncapped RNA, followed by oligonucleotide depletion of
the most abundant transcripts.
Overall, using the geometric mean coverage for each
gene across the seven time points measured, we reca-
pitulate the periodic gene expression patterns previously
reported (Bozdech et al., 2003; Le Roch et al., 2003).
Using a parallel analysis of the same samples used for
deep sequencing by DNA microarrays resulted in a good
correlation between these independent methods. The
sequencing data provide an expanded IDC transcrip-
tome because we were able to capture the transcript
abundance for lower abundance species, resulting in
4871 transcripts detected during the erythrocytic stages
of P. falciparum life cycle, suggesting that roughly 90%
of the genome is transcriptionally active during this
stage. Some genes that are known to be expressed in
other life cycle stages (such as PFI0185w, expressed in
gametocytes, Fig. 3) show no expression during the
IDC. In addition to improved sensitivity in detecting tran-
script expression, these higher resolution RNA-Seq data
provide detailed structural data for each of these 4871
transcripts.
We have used the RNA-Seq data for the veriﬁcation
and correction of existing gene models and to create a
number of new gene models: 423 existing gene models
were corrected and 121 new genes were added to the
current annotations. Seventy-ﬁve per cent of splice sites
were conﬁrmed with at least two read pairs. For all novel
transcripts detected here, we also report the gene expres-
sion patterns during parasite development in red blood
cells. Future improvement in technology such as
increased read length, larger insert sizes and strand-
speciﬁc reads will dramatically improve overall mapability,
our ability to analyse splice sites and UTRs, and possibly
to identify anti-sense transcripts. RNA-Seq of additional
life cycle stages such as gametocytes, oocytes, sporozoi-
tes and liver stages is also expected to unravel stage-
speciﬁc alternative splicing events and add more new
transcripts.
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which is perhaps unexpected, because in many higher
eukaryotes over half of transcripts are alternatively
spliced (Zavolan and van Nimwegen, 2006). A recent
study seeking to identify alternative splicing in late-stage
schizont genes and in gametocytes found alternative
splicing for 16% of the 88 open reading frames charac-
terized (Iriko et al., 2009), but found only two events of
alternative splicing in the blood stages. While we detected
84 alternative splicing events, we anticipate that with
increased sequencing read length, it will become easier to
identify bridging reads and thus enhance our current
understanding of the role of alternative splicing. A major
question that remains unanswered is what mechanisms
are being used to regulate the production of alternative
splice forms and are they functional?
The true power of RNA-Seq is that from one experi-
ment, the full transcript, from transcription start site to
polyadenylation signal, will be captured. Unfortunately,
due to the high A+T content of the P. falciparum genome
as well as the prevalence of low complexity regions, this
study falls short of providing signiﬁcant information about
non-coding regions. Undoubtedly, on a per-gene basis,
there is a lot of information to be gained, but this is difficult
to generalize computationally across the genome.
The results of this work demonstrate how RNA-Seq can
further our understanding of blood-stage transcription,
including insights into post-transcriptional events. Given
that our understanding of transcriptional regulation
remains poor for P. falciparum, accurate gene models of
RNA transcripts are essential. Ongoing efforts are under-
way to extend sequencing-based transcriptome analyses
to other Plasmodium life cycle stages including gameto-
cytogenesis, mosquito development and liver-stage
development. Of great interest is the sequencing of tran-
scripts from individual patient isolates to continue to
address the degree to which there are differences
between the in vivo and in vitro transcriptome of this
parasite as has been previously suggested (Daily et al.,
2007; Lemieux et al., 2009).
Experimental procedures
RNA preparation
Highly synchronous P. falciparum cultures were attained by
growing 50 ml cultures of parasites in RPMI 1640 culture
medium (with standard supplements) and using 5% sorbitol
to select for ring-stage parasites by standard methods
(Trager and Jensen, 1976; Lambros and Vanderberg, 1979).
Initially, one 50 ml culture (5% parasitaemia) was synchro-
nized 2 h post invasion and subsequently at 10 h, following
re-invasion, newly formed rings were again selected for with
two sorbitol treatments. The cultures were then expanded to
sufficient culture ﬂasks at a ﬁnal parasitaemia of 10%. Total
RNA from P. falciparum was isolated as described previously
(Bozdech et al., 2003). Brieﬂy, a TRIZOL extraction was per-
formed followed by an overnight sodium acetate in isopro-
panol precipitation, with a ﬁnal 70% ethanol wash.
Depletion protocol
For custom depletion of P. falciparum rRNAs and high-
abundance transcripts, 500 ml of streptavidin beads (Dyna-
beads, Invitrogen) was washed (10 mM Tris-HCl, pH 7.5,
1.0 mM EDTA, 2.0 M NaCl) three times and resuspended in
200 ml of the same buffer plus 200 ml of a mix of biotin-
labelled oligonucleotides (100 pmol of each) (Table S1) and
incubated at 37°C for 10 min. The beads were then washed
three times with 1 mM sodium citrate, pH 6.4. 25 mg of total
RNA was then incubated for 10 min at 65°C in a ﬁnal volume
of 200 ml 1 mM sodium citrate, 0.4 M guanidine, 1 ml
RNAseAway. After cooling to room temperature for 10 min,
the bound RNA was removed by magnetic puriﬁcation of the
beads. The free RNA was cleaned using a Zymo RNA
column. For Terminator™ 5′-Phosphate-Dependent Exonu-
clease (Epicentre) reactions, the manufacturer’s recommen-
dations were followed. Brieﬂy, 25 mgo fP. falciparum total
RNAwas incubated with 2 ml of exonuclease in a ﬁnal volume
of 40 ml for 1 h. After 1 h the reaction was stopped with 2 ml
0.1 mM EDTA, pH 8.0 and immediately added to the biotin-
labelled immobilized beads (see above). For P. falciparum,
cDNA synthesis and puriﬁcation, we used a combination of
random oligonucleotide and oligo(dT) primers as previously
published (Bozdech et al., 2003).
Sample preparation Solexa
Sequencing libraries for the Illumina GA II platform were
constructed by shearing the enriched cDNA by nebulisation
(35 psi, 6 min) followed by end-repair with Klenow poly-
merase, T4 DNA polymerase and T4 polynucleotide kinase
(to blunt-end the DNA fragments). A single 3′ adenosine
moiety was added to the cDNA using Klenow exo- and dATP.
The Illumina adapters (containing primer sites for sequencing
and ﬂowcell surface annealing) were ligated onto the repaired
ends on the cDNAand gel-electrophoresis was used to sepa-
rate library DNAfragments from unligated adapters by select-
ing cDNAfragments between 200 and 250 bp in size. Ligated
cDNA fragments were recovered following gel extraction at
room temperature to ensure representation of AT-rich
sequences. Libraries were ampliﬁed by 18 cycles of PCR with
Phusion DNA polymerase (Finnzymes Reagents).
The efficacy of each stage of library construction was
ascertained in a quality control step that involved measuring
the adapter-cDNA on an Agilent DNA 1000 chip. Sequencing
libraries diluted to 2 nM were denatured with sodium hydrox-
ide and diluted to 3.5 pM in hybridisation buffer for loading
onto a single lane of an Illumina GA ﬂowcell. Cluster forma-
tion, primer hybridisation and single-end (or read pairs) of
either 37 or 54 sequencing cycles were performed using
proprietary reagents according to manufacturer’s recom-
mended protocol (https://icom.illumina.com/).
As we used both 37 and 54 bp read pairs in this experi-
ment, we compared the RNA-Seq results from the sample
sequenced both ways. The correlation between the geomet-
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natural logarithm of the coverage of n unique bases of a given
CDS) was between 0.98 and 1.0. In the calculation of this
mean, non-unique regions of the gene were ignored. If one
read of a mate pair can be placed in a non-unique region, this
coverage is not counted.
Processing of Illumina data
Figure 1 describes the read-processing pipeline used in this
study. We used SSAHA2 (Ning et al., 2001) and SSA-
HA_pileup to align the Illumina reads against the P. falci-
parum 3D7 (version 2.1.4) reference genome. We also used
MAQ (Li et al., 2008) to investigate the success of the differ-
ent depletion strategies because MAQ randomly places
repetitive reads such as those aligning to rRNAsequences. In
the SSAHA2 mapping, we only included reads where one
end of the pair aligned uniquely to the genome and the
distance between the pairs was within the expected insert
size. The output of SSAHA_pileup was used to create the
coverage plots over the genome. We generated uniqueness
plots for all possible windows of 30 or 50 bp over the genome.
All repeat regions longer than the read length in a gene are
ignored for the expression calculation. To measure the
expression levels of each gene, we used the geometric
mean.
DNA microarray analysis
For each time point, 12 mg of total RNA was prepared for
hybridization by indirect amino-allyl cDNA labelling as previ-
ously described (Bozdech et al., 2003). A pool of 3D7 total
RNA from all IDC stages was utilized as the reference
sample. Array hybridizations were performed as described
using a recently designed new-generation P. falciparum-
speciﬁc long oligonucleotide DNA microarray (Hu et al.,
2007). The arrays were scanned using an Axon 4200A
scanner and images analysed using Axon GenePix software
(Axon Instruments, Union City, CA, USA). Due to technical
reasons, we were not able to successfully attain DNA
microarray hybridization data for the 40 h time point.
Correlation between RNA-Seq and DNA
microarray results
The IDC maps (Fig. 2) were created in R with the heatmap
command. The order for the genes was taken from Llinas
et al. (2006). The correlation with the microarray was also
calculated in R using the Pearson correlation. To compare the
correlation between the different read lengths, we used the
logarithm of the geometric mean of each CDS. For the com-
parison with the array data, we used the expression of CDS
of the 54 bp reads and compared it with the Cy5 values of the
array data. If for a given gene all time points of the array were
not available, the gene was ignored for the analysis.
Splice site determination
To ﬁnd new splice sites or to conﬁrm existing splice sites, we
used bridging reads. These are reads that would map over a
splice site in the nucleotide sequence of the gene, but in the
alignment output will split align to two different regions of a
chromosome, as they are mapping to two different exons. To
ﬁnd new splice sites, we look for reads that do not map
entirely on the CDS. We then required that these possible
splice site conﬁrming reads map with no more than one
mismatch to an existing CDS or a new exon and each part of
the read must have a match of at least 13 bp.
The non-mapping regions of the read provide information
about where another exon is beginning. Therefore, those
reads are remapped with SSAHA2 using very sensitive
parameters (-seeds 1 -score 10 -cmatch 9 -ckmer 6 -kmer 9
-cut 2000000 -skip 1), generating multiple partial hits. A read
identiﬁes a putative new splice site if two partial hits map to
the same chromosome and strand, their distance is less than
10 000 bp, and the genomic sequence contains a splice
donor (GT) and acceptor (AG).
To deﬁne alternative splicing (Table 3) we mapped all the
reads against gene models containing the new splice site and
counted how many reads conﬁrmed the new splice site. We
required at least two conﬁrming reads to call the potential
new splice site.
UTR coverage
To estimate the coverage of UTR regions, we analysed the
1 kb upstream and downstream regions of each CDS (pro-
viding this region did not overlap with another gene). We
counted the number of mapping reads and the amount of
covered bases for each 5′ and 3′ region.
RT-PCR veriﬁcation of RNA-Seq results
Twenty micrograms of mixed asexual stage total RNA pre-
pared according to the Trizol method was DNase treated and
cleaned up using a QIAgen RNeasy column before reverse
transcription using Superscript III (Invitrogen) with a 1:1
mixture of poly-dT : poly-dN according to manufacturer’s
protocol. One hundred nanograms of cDNAwas used in each
PCR reaction and run for 35 cycles. Primers used are listed
in Table S6.
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